C-SATS Funding: How Much Did They Raise & Key Investors

How Much Did C-SATS Raise?
Funding & Key Investors

C-SATS, a specialized entity within the Johnson & Johnson Family of Companies, has successfully secured significant capital to advance its mission of revolutionizing surgical performance metrics. The firm has reached a cumulative valuation milestone represented by $5.8M, bolstered by a recent strategic investment of $3.3M. This infusion of capital underscores the growing market demand for data-driven clinical oversight and the integration of artificial intelligence into standard surgical workflows.

The company's trajectory reflects a robust commitment to scaling its proprietary assessment platform, which serves as a critical infrastructure for hospitals aiming to standardize surgical excellence. By leveraging this latest financing, C-SATS is positioned to further refine its machine learning algorithms and expand its reach across the global healthcare landscape.

What is C-SATS?

C-SATS

Software

Healthcare Software

Education

C-SATS operates at the intersection of surgical education and advanced data analytics. The platform provides a sophisticated ecosystem where surgeons receive objective, near-real-time feedback on their technical performance. By utilizing a blend of machine learning, artificial intelligence, and human-led insights, the company enables medical professionals to access personalized dashboards, secure video libraries, and telementoring sessions. This approach effectively transforms subjective surgical evaluation into a quantifiable, continuous improvement process. Currently deployed in nearly 100 institutions, C-SATS is setting a new benchmark for patient outcomes through rigorous, evidence-based skill development and performance monitoring.

How much funding has C-SATS raised?

C-SATS has raised a total of $5.8M across 2 funding rounds:

2015

Unspecified

$2.5M

2016

Private Equity

$3.3M

Unspecified (2015): $2.5M, investors not publicly disclosed

Private Equity (2016): $3.3M, investors not publicly disclosed

Key Investors in C-SATS

C-SATS

Undisclosed investor participating in the funding round.

C-SATS

Undisclosed investor participating in the funding round.

C-SATS

Undisclosed investor participating in the funding round.

What's next for C-SATS?

With the support of its recent strategic investment, C-SATS is poised to accelerate its enterprise-level expansion. The focus will likely shift toward deepening the integration of its platform within the broader Johnson & Johnson surgical portfolio, potentially unlocking new synergies in robotic surgery and digital health. As the healthcare sector continues to prioritize value-based care, the demand for the objective, data-backed insights provided by C-SATS is expected to rise. Future growth initiatives will likely involve scaling the telementoring network and enhancing the predictive capabilities of its AI-driven assessment tools to ensure that surgeons remain at the forefront of clinical proficiency and patient safety.

See full C-SATS company page

See More Financial Insights